Tag : Amgen)

Latest News

Amgen to stop selling Repatha at higher list price, offer low-priced option exclusively

Newsemia
The biotech company had kept the drug available at the higher list price in order to give payers and pharmacy benefit managers time to adjust...
Latest News

Amgen, Astellas to pay government nearly $125M to resolve copay kickback allegations

Newsemia
The deal struck Thursday follows similar settlements between the Department of Justice and three other drugmakers. The department alleged that the companies started copay-assistance funds...
Latest News

Anti-Lymphotoxin – Pipeline Insight Report 2018 Featuring Roche, Zydus, Amgen & Biogen Idec – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Anti-Lymphotoxin -Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. ‘Anti-Lymphotoxin – Pipeline Insight, 2018’ report offers comprehensive insights of the...
Latest News

FDA approves Nivestym, biosimilar to Neupogen, for treatment of neutropenia

Newsemia
The FDA approved the biosimilar filgrastim-aafi, designed to promote white blood cell recovery among individuals who have undergone treatments that can trigger neutropenia.Filgrastim-aafi (Nivestym, Pfizer)...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy